Clinical data supports safety, bioavailability, and biological activity of pomegranate metabolite
Development of products with urolithin A, a metabolite from pomegranate compounds, took a big step forward as scientists reported results from a Phase 1 trial supporting the safety, bioavailability, and biological activity of the compound.

